药品注册申请号:214222
申请类型:ANDA (仿制药申请)
申请人:GLAND PHARMA LTD
申请人全名:GLAND PHARMA LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 15MG/VIAL No No AP 2021/03/08 2021/03/08 Prescription
002 THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 100MG/VIAL No No AP 2022/01/03 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/01/03 SUPPL-1(补充) Approval Manufacturing (CMC) UNKNOWN
2021/03/08 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:THIOTEPA 剂型/给药途径:POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 规格:15MG/VIAL 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
208264 001 NDA TEPADINA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 15MG/VIAL Prescription Yes Yes AP 2017/01/26 ADIENNE SA
213049 001 ANDA THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 15MG/VIAL Prescription No No AP 2020/03/04 MSN
214222 001 ANDA THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 15MG/VIAL Prescription No No AP 2021/03/08 GLAND PHARMA LTD
216037 001 ANDA THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 15MG/VIAL Prescription No No AP 2023/12/26 MEITHEAL
217559 001 ANDA THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 15MG/VIAL Prescription No No AP 2024/08/20 BELOTECA
活性成分:THIOTEPA 剂型/给药途径:POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 规格:100MG/VIAL 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
208264 002 NDA TEPADINA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 100MG/VIAL Prescription Yes Yes AP 2017/01/26 ADIENNE SA
213049 002 ANDA THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 100MG/VIAL Prescription No No AP 2020/03/04 MSN
214222 002 ANDA THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 100MG/VIAL Prescription No No AP 2022/01/03 GLAND PHARMA LTD
211755 001 ANDA THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 100MG/VIAL Prescription No No AP 2023/09/05 HIKMA
216037 002 ANDA THIOTEPA THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 100MG/VIAL Prescription No No AP 2023/12/26 MEITHEAL
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database